Quantum-dots based simultaneous detection of multiple biomarkers of tumor stromal features to predict clinical outcomes in gastric cancer

Biomaterials

Volumn 33, Issue 23, 2012, Pages 5742-5752

  Peng, Chun Wei ^a   Tian, Qian ^a   Yang, Gui Fang ^a   Fang, Min ^a   Zhang, Zhi Ling ^b   Peng, Jun ^c   Li, Yan ^a   Pang, Dai Wen ^b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c Wuhan Jiayuan Quantum Dots CO Ltd   (China)

Author keywords

Gastric cancer; Prognostic factors; Quantum dots; Tumor stromal features

Indexed keywords

BIOMARKERS; DISEASES; FEATURE EXTRACTION; NANOCRYSTALS; TUMORS;

DISEASE FREE SURVIVAL; GASTRIC CANCERS; INTEGRATED INFORMATIONS; PROGNOSTIC FACTORS; PROGNOSTIC SIGNIFICANCE; SIMULTANEOUS DETECTION; TUMOR MICROENVIRONMENT; TUMOR STROMAL FEATURES;

SEMICONDUCTOR QUANTUM DOTS;

COLLAGEN TYPE 4; ENDOGLIN; QUANTUM DOT; TUMOR MARKER;

ADULT; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MATURITY; OVERALL SURVIVAL; PRIORITY JOURNAL; STOMACH CANCER; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 84861348743     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.04.034     Document Type: Article

References (50)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. Ca-cancer J Clin 2011, 61(2):69-90.
2. Chiodoni C., Colombo M.P., Sangaletti S. Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis. Cancer Metast Rev 2010, 29(2):295-307.
3. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009, 9(4):239-252.
4. Anton K., Glod J. Targeting the tumor stroma in cancer therapy. Curr Pharm Biotechnol 2009, 10(2):185-191.
5. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674.
6. Squadrito M.L., De Palma M. Macrophage regulation of tumor angiogenesis: implications for cancer therapy. Mol Aspects Med 2011, 32(2):123-145.
7. Ono M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 2008, 99(8):1501-1506.
8. Pawelek J.M., Chakraborty A.K. Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer 2008, 8(5):377-386.
9. Wang R., Zhang J., Chen S., Lu M., Luo X., Yao S., et al. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression. Lung Cancer 2011, 74(2):188-196.
10. Ryder M., Ghossein R.A., Ricarte-Filho J.C., Knauf J.A., Fagin J.A. Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer 2008, 15(4):1069-1074.
11. Steidl C., Lee T., Shah S.P., Farinha P., Han G., Nayar T., et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010, 362(10):875-885.
12. Kim D.W., Min H.S., Lee K.H., Kim Y.J., Oh D.Y., Jeon Y.K., et al. High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer. Br J Cancer 2008, 98(6):1118-1124.
13. Jedinak A., Dudhgaonkar S., Sliva D. Activated macrophages induce metastatic behavior of colon cancer cells. Immunobiology 2010, 215(3):242-249.
14. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(1):57-70.
15. Kerbel R.S. Molecular origins of cancer: tumor angiogenesis. N Engl J Med 2008, 358(19):2039-2049.
16. Semenza G.L. Oxygen sensing, homeostasis, and disease. N Engl J Med 2011, 365(6):537-547.
17. Rolny C., Mazzone M., Tugues S., Laoui D., Johansson I., Coulon C., et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PIGF. Cancer Cell 2011, 19(1):31-44.
18. Sethi N., Kang Y.B. Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat Rev Cancer 2011, 11(10):735-748.
19. Bergers G., Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 2008, 8(8):592-603.
20. Goel S., Duda D.G., Xu L., Munn L.L., Boucher Y., Fukumura D., et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 2011, 91(3):1071-1121.
21. Chen C., Peng J., Sun S.R., Peng C.W., Li Y., Pang D.W. Tapping the potential of quantum dots for personalized oncology: current status and future perspectives. Nanomedicine 2012, 7(3):411-428.
22. Wittekind C., Meyer H.J. TNM classification of malignant tumours (ed 7) 2010, Wiley, Germany.
23. Peng C.W., Liu X.L., Chen C., Liu X., Yang X.Q., Pang D.W., et al. Patterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironment. Biomaterials 2011, 32(11):2907-2917.
24. Peng C.W., Liu X.L., Liu X., Li Y. Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance. J Transl Med 2010, 8:101.
25. Wang W., Li Y., Zhang Y., Yuan X., Xu D., Guan Y., et al. Incorporation of extranodal metastasis of gastric carcinoma into the 7th edition UICC TNM staging system. PLoS One 2011, 6(6):e19557.
26. Jung H., Lee H.H., Song K.Y., Jeon H.M., Park C.H. Validation of the seventh edition of the american joint committee on cancer TNM staging system for gastric cancer. Cancer 2011, 117:2371-2378.
27. Songun I., Putter H., Kranenbarg E.M.K., Sasako M., van de Velde C.J.H. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010, 11(5):439-449.
28. Bang Y.J., Van Cutsem E., Feyereislova A., Chung H.C., Shen L., Sawaki A., et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010, 376(9742):687-697.
29. Wang J., Ying G., Jung Y., Lu J., Zhu J., Pienta K.J., et al. Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression. Cancer Res 2010, 70(2):471-480.
30. Miselis N.R., Wu Z.J., Van Rooijen N., Kane A.B. Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma. Mol Cancer Ther 2008, 7(4):788-799.
31. Oosterling S.J., van der Bij G.J., Meijer G.A., Tuk C.W., van Garderen E., van Rooijen N., et al. Macrophages direct tumour histology and clinical outcome in a colon cancer model. J Pathol 2005, 207(2):147-155.
32. Psaila B., Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer 2009, 9(4):285-293.
33. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438(7069):820-827.
34. Comen E., Norton L., Massague J. Clinical implications of cancer self-seeding. Nat Rev Clin Oncol 2011, 8(6):369-377.
35. Kim M.Y., Oskarsson T., Acharyya S., Nguyen D.X., Zhang X.H., Norton L., et al. Tumor self-seeding by circulating cancer cells. Cell 2009, 139(7):1315-1326.
36. Mantovani A. Tumor-associated macrophages in cancer-related inflammation. Immunotherapy 2011, 3(4):21-22.
37. Mantovani A. B cells and macrophages in cancer: yin and yang. Nat Med 2011, 17(3):285-286.
38. Stockmann C., Doedens A., Weidemann A., Zhang N., Takeda N., Greenberg J.I., et al. Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature 2008, 456(7223):814-818.
39. Fischer C., Jonckx B., Mazzone M., Zacchigna S., Loges S., Pattarini L., et al. Anti-PIGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 2007, 131(3):463-475.
40. Mazzieri R., Pucci F., Moi D., Zonari E., Ranghetti A., Berti A., et al. Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 2011, 19(4):512-526.
41. Fantin A., Vieira J.M., Gestri G., Denti L., Schwarz Q., Prykhozhij S., et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010, 116(5):829-840.
42. Weilbaecher K.N., Guise T.A., McCauley L.K. Cancer to bone: a fatal attraction. Nat Rev Cancer 2011, 11(6):411-425.
43. Chen J., Yao Y., Gong C., Yu F., Su S., Chen J., et al. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell 2011, 19(4):541-555.
44. Zhu X.D., Zhang J.B., Zhuang P.Y., Zhu H.G., Zhang W., Xiong Y.Q., et al. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol 2008, 26(16):2707-2716.
45. Chen Q., Zhang X.H.F., Massague J. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell 2011, 20(4):538-549.
46. Zhou Q., Peng R.Q., Wu X.J., Xia Q., Hou J.-H., Ding Y., et al. The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J Transl Med 2010, 8:13.
47. Nguyen D.X., Bos P.D., Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009, 9(4):274-284.
48. Augsten M., Hagglof C., Pena C., Ostman A. A digest on the role of the tumor microenvironment in gastrointestinal cancers. Cancer Microenviron. 2010, 3(1):167-176.
49. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141(1):39-51.
50. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010, 11(10):889-896.